Ignite Creation Date:
2025-12-25 @ 2:35 AM
Ignite Modification Date:
2026-02-27 @ 5:16 PM
Study NCT ID:
NCT03486834
Status:
COMPLETED
Last Update Posted:
2024-01-23
First Post:
2018-03-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
V160 2-Dose and 3-Dose Regimens in Healthy Cytomegalovirus (CMV) Seronegative Females (V160-002)
Sponsor:
Merck Sharp & Dohme LLC
Organization: